Retrogenix is Discovery Tools (Healthcare) in United Kingdom that focus on target activities business. Founded in 2008. They cover business area such as developer, cell microarray technology, ligand-receptor interaction, secondary target activity, antibody, protein, small molecule, virus, pharmaceutical company, receptor identification, target deconvolution, off-target screening, CAR T cell, validation, result, FACS.
2008
( 16 years old in 2024 )
Target Activities
-
High Peak Business Park
Buxton Road, High Peak
Chinley SK23 6FJ
England, United Kingdom
Private
developercell microarray technologyligand-receptor interactionsecondary target activityantibodyproteinsmall moleculeviruspharmaceutical companyreceptor identificationtarget deconvolutionoff-target screeningCAR T cellvalidationresultFACS
* We use standard office opening hours in near Retrogenix's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Retrogenix is Discovery Tools (Healthcare) business from United Kingdom that founded in 2008 (16 years old in 2024), Retrogenix business is focusing on Target Activities.
Retrogenix headquarter office and corporate office address is located in High Peak Business Park Buxton Road, High Peak Chinley SK23 6FJ England, United Kingdom.
Retrogenix was founded in United Kingdom.
In 2024, Retrogenix is currently focus on target activities sector.
Above is snippet of Google Trends for "target activities" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Retrogenix, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
